TITLE

Inhaled nitric oxide in neonates

AUTHOR(S)
FINER, NEIL; Finer, N
PUB. DATE
September 1997
SOURCE
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep1997, Vol. 77 Issue 2, pF81
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66296263

 

Related Articles

  • AAP Statement on the Use of Inhaled Nitric Oxide. Preboth, Monica // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1238 

    Reports on a statement issued by the Committee on Fetus and Newborn of the American Academy of Pediatrics on the use of inhaled nitric oxide in newborns. Conditions under which inhaled nitric oxide should be administered to the neonate with hypoxic respiratory failure; Description of inhaled...

  • Inhaled nitric oxide worth it for neonatal pulmonary hypertension.  // PharmacoEconomics & Outcomes News;8/28/2004, Issue 460, p8 

    Presents the findings of a study on the cost effectiveness of using inhaled nitric oxide among neonates with persistent pulmonary hypertension in the U.S. Association of adding inhaled nitric oxide to the treatment regimen for pulmonary hypertension among neonates with treatment costs;...

  • Inhaled Nitric Oxide for Preterm Infants – Who Benefits? Martin, Richard J.; Walsh, Michele C. // New England Journal of Medicine;7/7/2005, Vol. 353 Issue 1, p82 

    The article explains the discrepant results of two studies that assessed the utility of inhaled nitric oxide in preterm neonates with respiratory failure. A recent study reports improved cognitive neurodevelopmental outcome in two-year-olds treated with inhaled nitric oxide as neonates. However,...

  • Nitric oxide. Young, Duncan // Continuing Education in Anaesthesia, Critical Care & Pain;Dec2002, Vol. 2 Issue 6, p161 

    This article discusses the use of nitric oxide in the treatment of diseases. It explains the ability of inhaled nitric oxide to reduce the use of extra-corporeal membrane oxygenation (ECMO) in neonates with pulmonary hypertension. It also notes the effectiveness of inhaled nitric oxide in...

  • Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension: 1-Year Follow-up. Clark, Reese H; Huckaby, Jeryl L; Kueser, Thomas J; Walker, Marshall W; Southgate, W Michael; Perez, Jose A; Roy, Beverly J; Keszler, Martin // Journal of Perinatology;Jun2003, Vol. 23 Issue 4, p300 

    BACKGROUND: Although inhaled nitric oxide has been shown to reduce the use of extracorporeal membrane oxygenation, there is limited data on its effect on long-term outcomes. OBJECTIVE: The purpose of our study is to report on the 1 year outcome of neonates treated with inhaled nitric oxide...

  • The 4th Congress of the European Academy of Paediatric Societies 5-9 October 2012.  // Archives of Disease in Childhood;Oct2012 Supplement 2, Vol. 97, pA1 

    The article presents abstracts on medical topics which include the quality improvement of pediatric primary care, use of innovative computerized inference algorithm (ICIA) for medical record maintenance and research on impact of inhaled nitric oxide on neonatal rats.

  • Early use of surfactant and nitric oxide. Null, D M // Journal of Perinatology;Dec2013, Vol. 33 Issue 12, p909 

    The author reflects on the study "Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure" by G. G. Konduri and colleagues. He expresses the potential of nitric oxide and surfactant to improve patient...

  • Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Hawkes, Michael; Opoka, Robert O; Namasopo, Sophie; Miller, Christopher; Thorpe, Kevin E; Lavery, James V; Conroy, Andrea L; Liles, W Conrad; John, Chandy C; Kain, Kevin C // Trials;2011, Vol. 12 Issue 1, p176 

    Background: Severe malaria remains a major cause of global morbidity and mortality. Despite the use of potent anti-parasitic agents, the mortality rate in severe malaria remains high. Adjunctive therapies that target the underlying pathophysiology of severe malaria may further...

  • Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Macrae, Duncan J.; Field, David; Mercier, Jean-Christophe; Møller, Jens; Stiris, Tom; Biban, Paolo; Cornick, Paul; Goldman, Allan; Göthberg, Sylvia; Gustafsson, Lars E.; Hammer, Jürg; Lönnqvist, Per-Arne; Sanchez-Luna, Manuel; Sedin, Gunnar; Subhedar, Nim; Møller, Jens; Göthberg, Sylvia; Hammer, Jürg; Lönnqvist, Per-Arne // Intensive Care Medicine;Mar2004, Vol. 30 Issue 3, p372 

    Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting...

  • Neonatology, then and now. Shulman, Stanford T. // Pediatric Annals;Sep2003, Vol. 32 Issue 9, p562 

    The article discusses various reports within the issue including one by Alfred Krauss on the advances in neonatal respiratory disease that relate to the assessment of fetal dating, steroid usage, surfactant therapy, ventilatory techniques, and the use of inhaled nitric oxide and another one by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics